Abstract:BACKGROUND: <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In general populations, healthy lifestyle is associated with fewer adverse outcomes. We estimated the degree to which adherence to a healthy lifestyle decreases the risk of renal and cardiovascular events among adults with chronic kidney disease (CKD).</AbstractText>STUDY DESIGN: <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Prospective cohort.</AbstractText>SETTING & PARTICIPANTS: <AbstractText Label="SETTING &amp; PARTICIPANTS" NlmCategory="METHODS">3,006 adults enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study.</AbstractText>PREDICTORS: <AbstractText Label="PREDICTORS" NlmCategory="METHODS">4 lifestyle factors (regular physical activity, body mass index [BMI] of 20-&lt;25kg/m(2), nonsmoking, and "healthy diet"), individually and in combination.</AbstractText>OUTCOMES: <AbstractText Label="OUTCOMES" NlmCategory="RESULTS">CKD progression (50% decrease in estimated glomerular filtration rate or end-stage renal disease), atherosclerotic events (myocardial infarction, stroke, or peripheral arterial disease), and all-cause mortality.</AbstractText>MEASUREMENTS: <AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">Multivariable-adjusted Cox proportional hazards.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">During a median follow-up of 4 years, we observed 726 CKD progression events, 355 atherosclerotic events, and 437 deaths. BMI≥25kg/m(2) and nonsmoking were associated with reduced risk of CKD progression (HRs of 0.75 [95% CI, 0.58-0.97] and 0.61 [95% CI, 0.45-0.82] for BMIs of 25 to &lt;30 and ≥30kg/m(2), respectively, versus 20 to &lt;25kg/m(2); HR for nonsmoking of 0.68 [95% CI, 0.55-0.84] compared to the current smoker reference group) and reduced risk of atherosclerotic events (HRs of 0.67 [95% CI, 0.46-0.96] for BMI of 25-&lt;30 vs 20-&lt;25kg/m(2) and 0.55 [95% CI, 0.40-0.75] vs current smoker). Factors associated with reduced all-cause mortality were regular physical activity (HR, 0.64 [95% CI, 0.52-0.79] vs inactive), BMI≥30kg/m(2) (HR, 0.64 [95% CI, 0.43-0.96] vs 20-&lt;25kg/m(2)), and nonsmoking (HR, 0.45 [95% CI, 0.34-0.60] vs current smoker). BMI&lt;20kg/m(2) was associated with increased all-cause mortality risk (HR, 2.11 [95% CI, 1.13-3.93] vs 20-&lt;25kg/m(2)). Adherence to all 4 lifestyle factors was associated with a 68% lower risk of all-cause mortality compared to adherence to no lifestyle factors (HR, 0.32; 95% CI, 0.11-0.89).</AbstractText>LIMITATIONS: <AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Lifestyle factors were measured only once.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Regular physical activity, nonsmoking, and BMI≥25kg/m(2) were associated with lower risk of adverse outcomes in this cohort of individuals with CKD.</AbstractText>

Adherence to healthy lifestyle was associated with an attenuation of the risk of chronic kidney disease from metabolic dysfunction-associated fatty liver disease: Results from two prospective cohorts

Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study.

The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study

Abstract 13759: Adherence to Healthy Lifestyle is Associated with Lower Total and Cause-Specific Mortality Risk among Patients with Diabetes: the UK Biobank Study

Associations Between Healthy Lifestyle and All-Cause Mortality in Individuals with Metabolic Associated Fatty Liver Disease

Healthy Lifestyle and Risk of Kidney Disease Progression, Atherosclerotic Events, and Death in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study

Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study

Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China

MAFLD and Risk of CKD.

Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis.

Associations of an Overall Healthy Lifestyle with the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease

Association between Lifestyle Modification and All-Cause, Cardiovascular, and Premature Mortality in Individuals with Non-Alcoholic Fatty Liver Disease

Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study

Healthy Lifestyle Is Associated with Reduced Mortality in Patients with Non-Alcoholic Fatty Liver Disease

Healthy Lifestyle Decreases the Risk of the First Incidence of Non-Communicable Chronic Disease and Its Progression to Multimorbidity and Its Mediating Roles of Metabolic Components: a Prospective Cohort Study in China.

Short-Term Weight Loss Decreased the Risk of Chronic Kidney Disease in Incident NAFLD Participants: A Prospective Cohort

The Role of Lifestyle Factors on Comorbidity of Chronic Liver Disease and Cardiometabolic Disease in Chinese Population: A Prospective Cohort Study.

Short‐term weight loss decreased the risk of chronic kidney disease in men with incident nonalcoholic fatty liver disease

New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate with the Risk of Incident Chronic Kidney Disease

The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease

The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.